| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Kalra Balkrishan | President and CEO, Director | C/O GENPACT LLC, 521 FIFTH AVENUE, 14TH FLOOR, NEW YORK | /s/ Thomas D. Scholtes, as Attorney-in-fact for Balkrishan Kalra | 13 Jan 2026 | 0001768217 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | G | Common Shares | Tax liability | $1,432,294 | -29,691 | -7.1% | $48.24 | 390,685 | 10 Jan 2026 | Direct | F1 |
| Id | Content |
|---|---|
| F1 | Represents shares withheld for payment of taxes upon the vesting of restricted share units granted under the Genpact Limited 2017 Omnibus Incentive Compensation Plan and exempt under Rule 16b-3. |